Biocon Limited (which holds around 78 per cent) will acquire the remaining stake in Biocon Biologics through a share swap…
” We are doing $1-2 million run rate revenue in the US. We expect the US business to be larger…
Wall Street projects the global weight-loss drug market could reach $150 billion by 2030, with Lilly and Novo Nordisk expected…
Indian pharma exporters had for several months faced the rhetoric and threats from the Trump administration to impose tariffs on…
Three pharma companies that have delivered the highest average 5-year ROCE are all into manufacturing the same type of products.…
After months of hearings, the Delhi High Court delivered the landmark ruling which cleared the way for Natco Pharma to…
Industry experts debate if the revised Promotion of Research and Innovation in Pharma-MedTech Sector (PRIP) scheme, with a Rs 5,000 crore…
Swiss healthcare giant Roche Pharma announced a major expansion, committing 1.5 billion Swiss francs ($1.9 billion) investment in India over…
Lupin to acquire VISUfarma for €190 million, enhancing its European presence and ophthalmology portfolio with over 60 eye health products.
Dividend stocks this week, September 28: Glenmark Pharma trades ex-dividend on Oct 3; watch for interim Rs 2.5 payout. Check…
Indian pharma stocks fell up to 7% in reaction to the US imposing a 100% tariff on imported branded and…
Nifty Pharma index drops over 2% after Trump unveils 100% tariff on drug imports – see which stocks are most…
Natco Pharma plans to demerge its agro business from core pharma to unlock value, enhance focus, and ensure dedicated management.
The scheme, announced in August 2023, is aimed at fostering innovation in the pharmaceutical and medical devices sectors, with a total financial…
Government clarifies re-labelling of medicines is not mandatory as new GST rates take effect from September 22.
Zydus Lifesciences has launched VaxiFlu, India’s first trivalent influenza vaccine for seasonal flu protection. The vaccine follows WHO’s 2025–26 guidelines…
Allowing data exclusivity would prevent the drug regulator — Central Drugs Standard Control Organisation — from granting marketing approval for…
Investors are increasingly turning to ‘safer’ MNC pharma stocks with a domestic focus at a time when the Trump administration…

The US economy grew faster than expected in the third quarter of the year, according to a delayed report released by the Commerce Department on Tuesday. The report showed that gross domestic product, or GDP, expanded by 4.3% between July and September, far above economists’ expectations of 3.2%.